L.J. Altfest & Co’s Eli Lilly LLY Stock Holding History

L.J. Altfest & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.4M	Buy	15,312 +3,524	+30%	+$3.6M	1.78%	14
2026 Q1	$10.8M	Sell	11,788 -905	-7%	-$917K	1.16%	19
2025 Q4	$13.6M	Sell	12,693 -1,109	-8%	-$1.06M	1.49%	19
2025 Q3	$10.5M	Buy	13,802 +3,321	+32%	+$2.47M	1.18%	21
2025 Q2	$8.17M	Buy	10,481 +913	+10%	+$709K	0.96%	24
2025 Q1	$7.9M	Sell	9,568 -9	-0.1%	-$7.49K	0.99%	24
2024 Q4	$7.39M	Sell	9,577 -9	-0.1%	-$7.45K	0.94%	27
2024 Q3	$8.49M	Buy	9,586 +1,262	+15%	+$1.13M	1.13%	23
2024 Q2	$7.54M	Buy	8,324 +355	+4%	+$284K	1.03%	26
2024 Q1	$6.2M	Buy	7,969 +59	+0.7%	+$42K	0.88%	27
2023 Q4	$4.61M	Sell	7,910 -317	-4%	-$185K	0.67%	32
2023 Q3	$4.42M	Sell	8,227 -39	-0.5%	-$20.1K	0.7%	27
2023 Q2	$3.88M	Sell	8,266 -47	-0.6%	-$19.7K	0.58%	31
2023 Q1	$2.85M	Sell	8,313 -24	-0.3%	-$8.09K	0.45%	35
2022 Q4	$3.05M	Sell	8,337 -830	-9%	-$294K	0.51%	41
2022 Q3	$2.96M	Sell	9,167 -229	-2%	-$72.6K	0.56%	28
2022 Q2	$3.05M	Sell	9,396 -1,835	-16%	-$551K	0.55%	34
2022 Q1	$3.22M	Sell	11,231 -197	-2%	-$50.7K	0.57%	30
2021 Q4	$3.16M	Sell	11,428 -578	-5%	-$147K	0.6%	34
2021 Q3	$2.77M	Buy	12,006 +410	+4%	+$101K	0.58%	29
2021 Q2	$2.66M	Buy	11,596 +537	+5%	+$108K	0.57%	32
2021 Q1	$2.07M	Buy	11,059 +184	+2%	+$36K	0.49%	41
2020 Q4	$1.84M	Buy	10,875 +1,575	+17%	+$235K	0.45%	39
2020 Q3	$1.38M	Sell	9,300 -337	-3%	-$52.2K	0.37%	46
2020 Q2	$1.58M	Buy	9,637 +817	+9%	+$125K	0.46%	39
2020 Q1	$1.22M	Buy	8,820 +12	+0.1%	+$1.65K	0.38%	44
2019 Q4	$1.16M	Sell	8,808 -80	-0.9%	-$9.27K	0.29%	52
2019 Q3	$994K	Sell	8,888 -111	-1%	-$12.4K	0.26%	60
2019 Q2	$997K	Buy	8,999 +62	+0.7%	+$7.3K	0.27%	62
2019 Q1	$1.16M	Sell	8,937 -66	-0.7%	-$8.03K	0.28%	55
2018 Q4	$1.04M	Sell	9,003 -62	-0.7%	-$6.93K	0.29%	51
2018 Q3	$973K	Sell	9,065 -80	-0.9%	-$8K	0.28%	65
2018 Q2	$780K	Sell	9,145 -844	-8%	-$69.3K	0.29%	71
2018 Q1	$773K	Sell	9,989 -6,510	-39%	-$524K	0.33%	70
2017 Q4	$1.39M	Buy	16,499 +72	+0.4%	+$6.13K	0.53%	44
2017 Q3	$1.41M	Sell	16,427 -421	-2%	-$34.5K	0.68%	35
2017 Q2	$1.39M	Buy	16,848 +9,848	+141%	+$803K	0.84%	37
2017 Q1	$589K	Hold	7,000	–	–	0.23%	77
2016 Q4	$515K	Hold	7,000	–	–	0.26%	80
2016 Q3	$562K	Hold	7,000	–	–	0.37%	72
2016 Q2	$551K	Buy	7,000 +200	+3%	+$15.1K	0.38%	75
2016 Q1	$490K	Hold	6,800	–	–	0.5%	56
2015 Q4	$573K	Hold	6,800	–	–	0.56%	55
2015 Q3	$569K	Hold	6,800	–	–	0.56%	54
2015 Q2	$568K	Sell	6,800 -275	-4%	-$21K	0.52%	56
2015 Q1	$514K	Hold	7,075	–	–	0.48%	55
2014 Q4	$488K	Buy	+7,075	New	+$478K	0.4%	68
2014 Q2	–	Sell	-7,072	Closed	-$413K	–	78
2014 Q1	$413K	Buy	7,072 +131	+2%	+$7.31K	0.38%	68
2013 Q4	$354K	Buy	+6,941	New	+$348K	0.3%	78

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

L.J. Altfest & Co's LLY Position: Q2 2026 in Review

L.J. Altfest & Co increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $3.6M and bringing the position to 15,312 shares worth $18.4M. The position accounts for 1.78% of the portfolio, ranked #14.

L.J. Altfest & Co first reported a position in LLY in Q4 2013 and has held it in 49 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

L.J. Altfest & Co held 15,312 shares of Eli Lilly worth $18.4M as of Q2 2026.
L.J. Altfest & Co bought 3,524 Eli Lilly shares in Q2 2026, an estimated $3.6M.
Eli Lilly made up 1.78% of L.J. Altfest & Co's portfolio in Q2 2026, its #14 holding.
L.J. Altfest & Co first reported a position in Eli Lilly in Q4 2013 and has held it in 49 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on L.J. Altfest & Co's 13F filing for Q2 2026, filed 30 Jul 2026.